{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:10:52Z","timestamp":1784848252324,"version":"3.55.0"},"reference-count":14,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1001\/jamaophthalmol.2018.4892","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T15:53:21Z","timestamp":1541087601000},"page":"87","source":"Crossref","is-referenced-by-count":25,"title":["Association of Intravitreal Injections With Blood Pressure Increase"],"prefix":"10.1001","volume":"137","author":[{"given":"Vanessa","family":"Berger","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, Department of BioMedical Research, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion R.","family":"Munk","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, Department of BioMedical Research, University of Bern, Bern, Switzerland"},{"name":"Bern Photographic Reading Center, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Lersch","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Inselspital, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wolf","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, Department of BioMedical Research, University of Bern, Bern, Switzerland"},{"name":"Bern Photographic Reading Center, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ebneter","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, Department of BioMedical Research, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Zinkernagel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, Bern University Hospital, Department of BioMedical Research, University of Bern, Bern, Switzerland"},{"name":"Bern Photographic Reading Center, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"ebr180019r2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ophtha.2011.12.039","article-title":"Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.","volume":"119","author":"Nguyen","year":"2012","journal-title":"Ophthalmology"},{"issue":"11","key":"ebr180019r3","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.ophtha.2014.05.006","article-title":"Intravitreal aflibercept for diabetic macular edema.","volume":"121","author":"Korobelnik","year":"2014","journal-title":"Ophthalmology"},{"issue":"10","key":"ebr180019r4","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.ophtha.2013.02.034","article-title":"Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials. RISE and RIDE.","volume":"120","author":"Brown","year":"2013","journal-title":"Ophthalmology"},{"issue":"9","key":"ebr180019r5","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1097\/IAE.0b013e31825db6ba","article-title":"Cerebrovascular accidents in patients treated for choroidal neovascularization with ranibizumab in randomized controlled trials.","volume":"32","author":"Bressler","year":"2012","journal-title":"Retina"},{"issue":"11","key":"ebr180019r6","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.ophtha.2014.05.022","article-title":"Systemic vascular safety of ranibizumab for age-related macular degeneration: systematic review and meta-analysis of randomized trials.","volume":"121","author":"Ueta","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"ebr180019r8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"issue":"28","key":"ebr180019r9","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"issue":"16","key":"ebr180019r10","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/jnci\/djm086","article-title":"Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.","volume":"99","author":"Scappaticci","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"ebr180019r11","doi-asserted-by":"publisher","first-page":"e89960","DOI":"10.1371\/journal.pone.0089960","article-title":"An updated meta-analysis of fatal adverse events caused by bevacizumab therapy in cancer patients.","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"ebr180019r12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3810\/pgm.2009.01.1950","article-title":"The diagnosis and treatment of hypertensive crises.","volume":"121","author":"Varon","year":"2009","journal-title":"Postgrad Med"},{"issue":"4","key":"ebr180019r13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/HJH.0b013e3282f4e8b6","article-title":"Association between hypertensive urgencies and subsequent cardiovascular events in patients with hypertension.","volume":"26","author":"Vlcek","year":"2008","journal-title":"J Hypertens"},{"issue":"3","key":"ebr180019r14","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1167\/iovs.17-22853","article-title":"Changes in blood pressure and urine albumin-creatinine ratio in a randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab for diabetic macular edema.","volume":"59","author":"Glassman","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ebr180019r1","unstructured":"BarronH. Important drug warning: MedWatch Genentech 2005. http:\/\/www.fda.gov\/medwatch\/SAFETY\/2005\/Avastin_dearhcp.pdf. Accessed June 14, 2018."},{"key":"ebr180019r7","unstructured":"McGlynnTJ, MetcallH, eds. Diagnosis and treatment of anxiety disorders. http:\/\/www.southlakepsych.org\/index.htm\/Patient_Forms_files\/SheehanAnxietyScale.pdf. Published 2008. Accessed June 14, 2018."}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2712693","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T16:05:25Z","timestamp":1547136325000},"score":1,"resource":{"primary":{"URL":"http:\/\/archopht.jamanetwork.com\/article.aspx?doi=10.1001\/jamaophthalmol.2018.4892"}},"subtitle":["The Following Excitement and Anxiety Response Under Intravitreal Injection Study"],"short-title":[],"issued":{"date-parts":[[2019,1,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2018.4892","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1,1]]}}}